CLINICAL_TRIALS
trial_result
· 2025-09-18
Clinical Trial Update: A Study of Glutathione in Children With Autism Spectrum Disorder [Phase 4]
Summary
Phase 4 trial evaluating glutathione in children with autism spectrum disorder was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Autism Spectrum Disorder | Phase 4 | Status: TERMINATED | Results posted: 2025-09-18